Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Raju Sunagar, Sudeep Kumar, Brian J Franz & Edmund J Gosselin. (2016) Tularemia vaccine development: paralysis or progress?. Vaccine: Development and Therapy 6, pages 9-23.
Read now
Read now
Max Maurin. (2015) Francisella tularensis as a potential agent of bioterrorism?. Expert Review of Anti-infective Therapy 13:2, pages 141-144.
Read now
Read now
Yan-Yan Zhang, Yong Liu, Shahila Mehboob, Jin-Hua Song, Teuta Boci, Michael E. Johnson, Arun K. Ghosh & Hyunyoung Jeong. (2014) Metabolism-directed structure optimization of benzimidazole-based Francisella tularensis enoyl-reductase (FabI) inhibitors. Xenobiotica 44:5, pages 404-416.
Read now
Read now
Tuba Celik, Mustafa Kosker & Elif Betul Turkoglu. (2013) Unilateral Acute Dacryocystitis Associated with Oculoglandular Tularemia: A Case Report. Seminars in Ophthalmology 28:2, pages 91-93.
Read now
Read now
Articles from other publishers (82)
Rebin Rafaat MohammedAhmad EnferadiKarzan R. SidiqSaeedeh SaraniPeyman KhademiAmin JaydariAvin Kawa Ahmed. (2023)
Molecular Detection of
Francisella tularensis
Isolated from Ticks of Livestock in Kurdistan Region, Iraq
. Vector-Borne and Zoonotic Diseases.
Crossref
Crossref
Léa Ponderand, Thomas Guimard, Estibaliz Lazaro, Henry Dupuy, Olivia Peuchant, Nathalie Roch, Philippe Deroche, Tristan Ferry, Max Maurin, Aurélie Hennebique, Sandrine Boisset, Isabelle Pelloux & Yvan Caspar. (2023)
Case Studies and Literature Review of
Francisella tularensis
–Related Prosthetic Joint Infection
. Emerging Infectious Diseases 29:6.
Crossref
Crossref
Phillip R. Pittman, Gunnstein Norheim, Benjamin Pierson & Fernando B. Guerena. 2023. Plotkin's Vaccines. Plotkin's Vaccines
172
190.e9
.
Nadezhda A. Byzova, Anatoly V. Zherdev, Alexey A. Gorbatov, Anton G. Shevyakov, Sergey F. Biketov & Boris B. Dzantiev. (2022) Rapid Detection of Lipopolysaccharide and Whole Cells of Francisella tularensis Based on Agglutination of Antibody-Coated Gold Nanoparticles and Colorimetric Registration. Micromachines 13:12, pages 2194.
Crossref
Crossref
Sahar Sabour, Taher Azimi, Ahmad Nasser, Nahal Hadi, Amin Mohsenzadeh & Aref Shariati. (2022) A global overview of the most important zoonotic bacteria pathogens transmitted from Rattus norvegicus to humans in urban environments. Infectious Medicine 1:3, pages 192-207.
Crossref
Crossref
Emre ARSLANBAŞ & Emine BAYDAN. (2022) EGZOTİK (YABANİ) HAYVANLARDAN KAYNAKLI ZOONOZLAR VE SAĞALTIMIEXOTIC (WILD) ANIMALS ORIGINATED ZOONOSES AND THEIR TREATMENT. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 13:2, pages 78-89.
Crossref
Crossref
Göran Ramin Boeckel, Jan Basri Adiprasito, Neele Judith Froböse, Frieder Schaumburg, Richard Vollenberg & Phil-Robin Tepasse. (2022) Tularemia Presenting Solely with Cervical Lymphadenopathy and Fever. Diagnostics 12:8, pages 2000.
Crossref
Crossref
Kevin D. Mlynek, Christopher T. Lopez, David P. Fetterer, Janice A. Williams & Joel A. Bozue. (2022) Phase Variation of LPS and Capsule Is Responsible for Stochastic Biofilm Formation in Francisella tularensis. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Maja Prah, Ana Kenk & Jana Rejc Marko. (2022) Skin involvement in Francisella tularensis infection: a case report of two clinical cases. Acta Dermatovenerologica Alpina Pannonica et Adriatica 31:2.
Crossref
Crossref
Pierre H. Boyer, Antoine Grillon, Benoît Jaulhac, Aurélie Velay, Frédéric Schramm & Emilie Talagrand-Reboul. 2022. Lyme Borreliosis. Lyme Borreliosis
193
234
.
Olivier Bahuaud, Cécile Le Brun & Adrien Lemaignen. (2021) Host Immunity and Francisella tularensis: A Review of Tularemia in Immunocompromised Patients. Microorganisms 9:12, pages 2539.
Crossref
Crossref
Veronika Merold, Kim Silberreis & Kilian Stoecker. (2021) Development and Validation of Ribosomal RNA-Targeted Reverse Transcription Real-Time PCR Assays for the Sensitive and Rapid Diagnostics of High Consequence Pathogens. Frontiers in Microbiology 12.
Crossref
Crossref
Emily E. Hannah, Sujata G. Pandit, Derrick Hau, Haley L. DeMers, Kayleigh Robichaux, Teerapat Nualnoi, Anjana Dissanayaka, Jose Arias-Umana, Heather R. Green, Peter Thorkildson, Kathryn J. Pflughoeft, Marcellene A. Gates-Hollingsworth, Yasemin Ozsurekci & David P. AuCoin. (2021) Development of Immunoassays for Detection of Francisella tularensis Lipopolysaccharide in Tularemia Patient Samples. Pathogens 10:8, pages 924.
Crossref
Crossref
Kay B. Barnes, Mark I. Richards, Thomas R. Laws, Alejandro Núñez, Joanne E. Thwaite, Christine Bentley & Sarah V. Harding. (2021) Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection. Antimicrobial Agents and Chemotherapy 65:6.
Crossref
Crossref
Caleb R. S. McEntire, Kun-Wei Song, Robert P. McInnis, John Y. Rhee, Michael Young, Erika Williams, Leah L. Wibecan, Neal Nolan, Amanda M. Nagy, Jeffrey Gluckstein, Shibani S. Mukerji & Farrah J. Mateen. (2021) Neurologic Manifestations of the World Health Organization's List of Pandemic and Epidemic Diseases. Frontiers in Neurology 12.
Crossref
Crossref
N. Tissot, S. Noureddine, M. Guion-Dusserre & T. Soumagne. (2021) Bilan d’adénopathies médiastinales : ne pas méconnaître une tularémie !. Revue des Maladies Respiratoires 38:2, pages 204-209.
Crossref
Crossref
Sanjana Vijay Nemade & Kiran Jaywant ShindeSanjana Vijay Nemade & Kiran Jaywant Shinde. 2021. Granulomatous diseases in Otorhinolaryngology, Head and Neck. Granulomatous diseases in Otorhinolaryngology, Head and Neck
95
100
.
Zakaria Abdellahoum, Max Maurin & Idir Bitam. (2020) Tularemia as a Mosquito-Borne Disease. Microorganisms 9:1, pages 26.
Crossref
Crossref
Vivien Sutera, Aurélie Hennebique, Fabrice Lopez, Nicolas Fernandez, Dominique Schneider & Max Maurin. (2020) Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain. International Journal of Antimicrobial Agents 56:6, pages 106153.
Crossref
Crossref
Fabrice V. Biot, Beth A. Bachert, Kevin D. Mlynek, Ronald G. Toothman, Galina I. Koroleva, Sean P. Lovett, Christopher P. Klimko, Gustavo F. Palacios, Christopher K. Cote, Jason T. Ladner & Joel A. Bozue. (2020) Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness. Frontiers in Microbiology 11.
Crossref
Crossref
Max Maurin. (2020) Francisella tularensis, Tularemia and Serological Diagnosis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Sofiane Regoui, Aurélie Hennebique, Thomas Girard, Sandrine Boisset, Yvan Caspar & Max Maurin. (2020) Optimized MALDI TOF Mass Spectrometry Identification of Francisella tularensis Subsp. holarctica. Microorganisms 8:8, pages 1143.
Crossref
Crossref
Max Maurin. 2020. Hunter's Tropical Medicine and Emerging Infectious Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases
630
635
.
Jayant Patwa & S.J.S. Flora. 2020. Handbook on Biological Warfare Preparedness. Handbook on Biological Warfare Preparedness
151
172
.
Ryan C. Maves & Catherine M. Berjohn. 2020. Highly Infectious Diseases in Critical Care. Highly Infectious Diseases in Critical Care
97
118
.
Saber Esmaeili, Ahmad Ghasemi, Razi Naserifar, Ali Jalilian, Leila Molaeipoor, Max Maurin & Ehsan Mostafavi. (2019) Epidemiological survey of tularemia in Ilam Province, west of Iran. BMC Infectious Diseases 19:1.
Crossref
Crossref
Todd M. Kijek, Sherry Mou, Beth A. Bachert, Kathleen A. Kuehl, Janice A. Williams, Sharon P. Daye, Patricia L. Worsham & Joel A. Bozue. (2019) The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge. Microbial Pathogenesis 137, pages 103742.
Crossref
Crossref
Kay B. Barnes, Karleigh A. Hamblin, Mark I. Richards, Thomas R. Laws, Andreas Vente, Helen S. Atkins & Sarah V. Harding. (2019) The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4. Frontiers in Microbiology 10.
Crossref
Crossref
Christina A. Nelson, Christian Murua, Jefferson M. Jones, Kelli Mohler, Ying Zhang, Landon Wiggins, Natalie A. Kwit, Laurel Respicio-Kingry, Luke C. Kingry, Jeannine M. Petersen, Jennifer Brown, Saima Aslam, Melissa Krafft, Shadaba Asad, Hikmat N. Dagher, John Ham, Luis H. Medina-Garcia, Kevin Burns, Walter E. Kelley, Alison F. Hinckley, Pallavi Annambhotla, Karen Carifo, Anthony Gonzalez, Elizabeth Helsel, Joseph Iser, Michael Johnson, Curtis L. Fritz & Sridhar V. Basavaraju. (2019)
Francisella tularensis
Transmission by Solid Organ Transplantation, 20171
. Emerging Infectious Diseases 25:4, pages 767-775.
Crossref
Crossref
J. Heichel, E. Luci, H.-G. Struck, U. Siebolts, C. Wickenhauser, S. Plontke, A. Viestenz & G. Götze. (2018) Sekundär erworbene Tränenwegsstenose und zervikale LymphadenopathieSecondary acquired lacrimal duct obstruction and cervical lymphadenopathy. HNO 66:11, pages 847-850.
Crossref
Crossref
L. A. Dykman, O. A. Volokh, E. M. Kuznetsova & A. K. Nikiforov. (2019) Immunogenicity of Conjugates of Protective Antigen Complexes of Tularemia Microbe with Gold Nanoparticles. Nanotechnologies in Russia 13:7-8, pages 384-392.
Crossref
Crossref
Jinhong Ren, Tina L. Mistry, Pin-Chih Su, Shahila Mehboob, Robel Demissie, Leslie Wo-Mei Fung, Arun K. Ghosh & Michael E. Johnson. (2018) Determination of absolute configuration and binding efficacy of benzimidazole-based FabI inhibitors through the support of electronic circular dichroism and MM-GBSA techniques. Bioorganic & Medicinal Chemistry Letters 28:11, pages 2074-2079.
Crossref
Crossref
Alisa W. Serio, Tiffany Keepers, Logan Andrews & Kevin M. Krause. (2018) Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. EcoSal Plus 8:1.
Crossref
Crossref
Hadjila Yanes, Aurélie Hennebique, Isabelle Pelloux, Sandrine Boisset, Dominique J. Bicout, Yvan Caspar & Max Maurin. (2018) Evaluation of In-House and Commercial Serological Tests for Diagnosis of Human Tularemia. Journal of Clinical Microbiology 56:1.
Crossref
Crossref
Phillip R. Pittman & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
149
160.e7
.
Elamparithi Jayamani, Nagendran Tharmalingam, Rajmohan Rajamuthiah, Jeffrey J. Coleman, Wooseong Kim, Ikechukwu Okoli, Ana M. Hernandez, Kiho Lee, Gerard J. Nau, Frederick M. Ausubel & Eleftherios Mylonakis. (2017) Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds. Antimicrobial Agents and Chemotherapy 61:9.
Crossref
Crossref
V. Sutera, G. Hoarau, P. Renesto, Y. Caspar & M. Maurin. (2017) In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis , including in tularaemia patients with treatment failure. International Journal of Antimicrobial Agents 50:3, pages 377-383.
Crossref
Crossref
Taylor Chance, Jennifer Chua, Ronald G. Toothman, Jason T. Ladner, Jonathan E. Nuss, Jo Lynne Raymond, Fabrice V. Biot, Samandra Demons, Lynda Miller, Stephanie Halasohoris, Sherry Mou, Galina Koroleva, Sean Lovett, Gustavo Palacios, Nicholas J. Vietri, Patricia L. Worsham, Christopher K. Cote, Todd M. Kijek & Joel A. Bozue. (2017) A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia. PLOS ONE 12:3, pages e0174106.
Crossref
Crossref
Herbert Tomaso & Helmut Hotzel. (2017) Tularemia from a One Health Perspective. Current Clinical Microbiology Reports 4:1, pages 36-42.
Crossref
Crossref
Padmapriya P. Banada, Srinidhi Deshpande, Soumitesh Chakravorty, Riccardo Russo, James Occi, Gabriel Meister, Kelly J. Jones, Carl H. Gelhaus, Michelle W. Valderas, Martin Jones, Nancy Connell & David Alland. (2017) Sensitive Detection of Francisella tularensis Directly from Whole Blood by Use of the GeneXpert System. Journal of Clinical Microbiology 55:1, pages 291-301.
Crossref
Crossref
Michael O’Connell. 2017. Stinging Insect Allergy. Stinging Insect Allergy
247
268
.
Tereza Cristina Leal-Balbino, Maria Betânia Melo de Oliveira, Maria Paloma Silva de Barros, Marise Sobreira & Vladimir da Mota Silveira-Filho. 2017. Arthropod Borne Diseases. Arthropod Borne Diseases
155
170
.
Svetlana Lockwood, Kelly A. Brayton & Shira L. Broschat. (2016) Comparative genomics reveals multiple pathways to mutualism for tick-borne pathogens. BMC Genomics 17:1.
Crossref
Crossref
Natalie Williams‐Bouyer, Donald H. Bouyer & Michael J. Loeffelholz. 2016. Manual of Commercial Methods in Clinical Microbiology. Manual of Commercial Methods in Clinical Microbiology
184
194
.
Pin-Chih Su & Michael E. Johnson. (2016) Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors. Journal of Computational Chemistry 37:9, pages 836-847.
Crossref
Crossref
David Cipolla, Jim Blanchard & Igor Gonda. (2016) Development of Liposomal Ciprofloxacin to Treat Lung Infections. Pharmaceutics 8:1, pages 6.
Crossref
Crossref
Youngmin Seo, Ji-eun Kim, Yoon Jeong, Kwan Hong Lee, Jangsun Hwang, Jongwook Hong, Hansoo Park & Jonghoon Choi. (2016) Engineered nanoconstructs for the multiplexed and sensitive detection of high-risk pathogens. Nanoscale 8:4, pages 1944-1951.
Crossref
Crossref
Max Maurin & Miklós Gyuranecz. (2016) Tularaemia: clinical aspects in Europe. The Lancet Infectious Diseases 16:1, pages 113-124.
Crossref
Crossref
Christian Sandrock. 2016. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine
699
712.e2
.
Ji-eun Kim, Youngmin Seo, Yoon Jeong, Mintai P. Hwang, Jangsun Hwang, Jaebum Choo, Jong Wook Hong, Jun Ho Jeon, Gi-eun Rhie & Jonghoon Choi. (2015) A novel nanoprobe for the sensitive detection of Francisella tularensis. Journal of Hazardous Materials 298, pages 188-194.
Crossref
Crossref
Waldemar Rastawicki, Natalia Rokosz-Chudziak, Anna Chróst & Rafał Gierczyński. (2015) Development and evaluation of a latex agglutination test for the rapid serodiagnosis of tularemia. Journal of Microbiological Methods 112, pages 1-2.
Crossref
Crossref
Sara Moutailler, Jean-Claude George, Yves Hansmann, Brigitte Degeilh, Guy Joncour, Elsa Jourdain, Laurence Malandrin, Gérald Umhang, Muriel Vayssier‑Taussat, Laurence Vial, Sarah Bonnet & Nathalie Boulanger. 2015. Tiques et maladies à tiques. Tiques et maladies à tiques
193
209
.
Oto Pavlis, Eva Kusakova, Ladislav Novotny & Miroslav Pohanka. (2014) Organs of BALB/c mice can be injured in course of tularemia. Biomedical Papers 158:4, pages 557-561.
Crossref
Crossref
Saber Esmaeili, Behzad Esfandiari, Max Maurin, Mohammad Mehdi Gouya, Mohammad Reza Shirzadi, Fahimeh Bagheri Amiri & Ehsan Mostafavi. (2014) Serological survey of tularemia among butchers and slaughterhouse workers in Iran. Transactions of The Royal Society of Tropical Medicine and Hygiene 108:8, pages 516-518.
Crossref
Crossref
Max Maurin & Isabelle Pelloux. (2014) Francisella tularensis et la tularémie. Revue Francophone des Laboratoires 2014:464, pages 31-35.
Crossref
Crossref
Karleigh A. Hamblin, Jonathan P. Wong, James D. Blanchard & Helen S. Atkins. (2014) The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy. Frontiers in Cellular and Infection Microbiology 4.
Crossref
Crossref
Karleigh A. Hamblin, Stuart J. Armstrong, Kay B. Barnes, Carwyn Davies, Jonathan P. Wong, James D. Blanchard, Sarah V. Harding, Andrew J. H. Simpson & Helen S. Atkins. (2014) Liposome Encapsulation of Ciprofloxacin Improves Protection against Highly Virulent Francisella tularensis Strain Schu S4. Antimicrobial Agents and Chemotherapy 58:6, pages 3053-3059.
Crossref
Crossref
Sandrine Boisset, Yvan Caspar, Vivien Sutera & Max Maurin. (2014) New therapeutic approaches for treatment of tularaemia: a review. Frontiers in Cellular and Infection Microbiology 4.
Crossref
Crossref
Sarah L. Newstead, Amanda J. Gates, M. Gillian Hartley, Caroline A. Rowland, E. Diane Williamson & Roman A. Lukaszewski. (2014)
Control of Intracellular
Francisella tularensis
by Different Cell Types and the Role of Nitric Oxide
. Journal of Immunology Research 2014, pages 1-8.
Crossref
Crossref
Vivien Sutera, Maxime Levert, Wim Pascal Burmeister, Dominique Schneider & Max Maurin. (2014) Evolution toward high-level fluoroquinolone resistance in Francisella species. Journal of Antimicrobial Chemotherapy 69:1, pages 101-110.
Crossref
Crossref
Saber Esmaeili, Mohammad Mehdi Gooya, Mohammad Reza Shirzadi, Behzad Esfandiari, Fahimeh Bagheri Amiri, Manijeh Yousefi Behzadi, Omid Banafshi & Ehsan Mostafavi. (2014) Seroepidemiological survey of tularemia among different groups in western Iran. International Journal of Infectious Diseases 18, pages 27-31.
Crossref
Crossref
Justin Jackson, Caroline Chen & Kirsty Buising. (2013) Aminoglycosides. Current Opinion in Infectious Diseases 26:6, pages 516-525.
Crossref
Crossref
M. V. Stundick, M. T. Albrecht, C. R. Houchens, A. Pierce Smith, T. M. Dreier & J. C. Larsen. (2013)
Animal Models for
Francisella tularensis
and
Burkholderia
Species
. Veterinary Pathology 50:5, pages 877-892.
Crossref
Crossref
Charlotte Dentan, Patricia Pavese, Isabelle Pelloux, Sandrine Boisset, Jean-Paul Brion, Jean-Paul Stahl & Max Maurin. (2013) Treatment of Tularemia in Pregnant Woman, France. Emerging Infectious Diseases 19:6, pages 996-998.
Crossref
Crossref
A. Ulu-Kilic, G. Gulen, F. Sezen, S. Kilic & I. Sencan. (2012) Tularemia in Central Anatolia. Infection 41:2, pages 391-399.
Crossref
Crossref
Max Maurin. 2013. Hunter's Tropical Medicine and Emerging Infectious Disease. Hunter's Tropical Medicine and Emerging Infectious Disease
591
596
.
Carey-Ann D. Burnham, Christopher Doern & Steven R. Binder. 2013. The Immunoassay Handbook. The Immunoassay Handbook
929
938
.
Shahila Mehboob, Kirk E. Hevener, Kent Truong, Teuta Boci, Bernard D. Santarsiero & Michael E. Johnson. (2012)
Structural and Enzymatic Analyses Reveal the Binding Mode of a Novel Series of
Francisella tularensis
Enoyl Reductase (FabI) Inhibitors
. Journal of Medicinal Chemistry 55:12, pages 5933-5941.
Crossref
Crossref
Anat Zvi, Shahar Rotem, Ofer Cohen & Avigdor Shafferman. (2012) Clusters versus Affinity-Based Approaches in F. tularensis Whole Genome Search of CTL Epitopes. PLoS ONE 7:5, pages e36440.
Crossref
Crossref
Kirk E. Hevener, Shahila Mehboob, Pin-Chih Su, Kent Truong, Teuta Boci, Jiangping Deng, Mahmood Ghassemi, James L. Cook & Michael E. Johnson. (2011) Discovery of a Novel and Potent Class of F. tularensis Enoyl-Reductase (FabI) Inhibitors by Molecular Shape and Electrostatic Matching. Journal of Medicinal Chemistry 55:1, pages 268-279.
Crossref
Crossref
D. Jacob, T. Wahab, B. Edvinsson, A. Peterzon, T. Boskani, L. Farhadi, A. Barduhn, R. Grunow & G. Sandström. (2011) Identification and subtyping of Francisella by pyrosequencing and signature matching of 16S rDNA fragments. Letters in Applied Microbiology 53:6, pages 592-595.
Crossref
Crossref
S. Mahy, P. Chavanet, L. Piroth, N. Roch, M. Duong, I. Pelloux & M. Maurin. (2011) Emergence of tularemia in France: paradigm of the Burgundy region. International Journal of Infectious Diseases 15:12, pages e882-e883.
Crossref
Crossref
M. Maurin, I. Pelloux, J. P. Brion, J.-N. Del Bano & A. Picard. (2011) Human Tularemia in France, 2006-2010. Clinical Infectious Diseases 53:10, pages e133-e141.
Crossref
Crossref
M. Pohanka, R. Chlibek, K. Kuca, H. Bandouchova & J. Pikula. (2011) Diagnosis of tularemia using biochemical, immunochemical and molecular methods: a review. Veterinární medicína 56:9, pages 453-461.
Crossref
Crossref
Anat Zvi, Shahar Rotem, Erez Bar-Haim, Ofer Cohen & Avigdor Shafferman. (2011) Whole-Genome Immunoinformatic Analysis of F. tularensis: Predicted CTL Epitopes Clustered in Hotspots Are Prone to Elicit a T-Cell Response. PLoS ONE 6:5, pages e20050.
Crossref
Crossref
Brieuc Gestin, Eric Valade, François Thibault, Dominique Schneider & Max Maurin. (2010) Phenotypic and genetic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I. Journal of Antimicrobial Chemotherapy 65:11, pages 2359-2367.
Crossref
Crossref
Michelle Nelson, Mark S. Lever, Rachel E. Dean, Peter C. Pearce, Daniel J. Stevens & Andrew J. H. Simpson. (2010)
Bioavailability and Efficacy of Levofloxacin against
Francisella tularensis
in the Common Marmoset (
Callithrix jacchus
)
. Antimicrobial Agents and Chemotherapy 54:9, pages 3922-3926.
Crossref
Crossref
Richard B. Pyles, G. Eric Jezek & Tonyia D. Eaves-Pyles. (2010)
Toll-Like Receptor 3 Agonist Protection against Experimental
Francisella tularensis
Respiratory Tract Infection
. Infection and Immunity 78:4, pages 1700-1710.
Crossref
Crossref
Kurugundla Navatha, Wei Li, Chukuma Okadigwe, Tom Russi & Rocco Franco. (2010) Tularemia presenting as a unilateral pleural effusion in a metropolitan city. Respiratory Medicine CME 3:3, pages 195-197.
Crossref
Crossref
Christian Sandrock. 2010. Murray and Nadel's Textbook of Respiratory Medicine. Murray and Nadel's Textbook of Respiratory Medicine
1636
1650
.
Erez Bar-Haim, Hila Cohen, Raphael Ber, Ofer Cohen & Avigdor Shafferman. 2010. The Challenge of Highly Pathogenic Microorganisms. The Challenge of Highly Pathogenic Microorganisms
207
212
.
Michael D. Valentino, Lucinda L. Hensley, Denise Skrombolas, Pamela L. McPherson, Matthew D. Woolard, Thomas H. Kawula, Jeffrey A. Frelinger & John G. Frelinger. (2009) Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Molecular Immunology 46:8-9, pages 1830-1838.
Crossref
Crossref